Medical Devices News and Research

RSS

Patrick K. Donnelly announces official launch of Aptiv Solutions

Chairman and CEO Patrick K. Donnelly today announced the official launch of Aptiv Solutions, a global biopharmaceutical and medical device development services company.

1 Jun 2011

First Edition: May 31, 2011

Today's headlines include articles on the federal efforts to improve hospital quality, the politics of Medicare and the move by some GOP governors to set up health exchanges.

31 May 2011

The demand of antimicrobials in the plastic business is growing. SANITIZED AG is following a strategy of direct commercialisation of its products in the Plastic Market. Its clients profit from a short time to market and professional consulting over the whole project process.

31 May 2011

New ways to replicate what happens to stents tucked inside blood vessels

If by chance you should have a stent inserted in a clogged coronary artery, you can probably count on it staying around for a very long time. So it's important to know what will happen to it.

27 May 2011

Sanofi-Aventis, Medtronic under scrutiny in press reports

ProPublica details alleged activities by Sanofi-Aventis to influence regulators regarding its brand-name blood thinner, Lovenox, while other news outlets report on Medtronic's activities related to a biological agent used in back surgery.

27 May 2011

Consistency and efficiency of FDA's medical device review process raises concern

Two-thirds of small medical device and diagnostic companies--the drivers of innovation in the sector--are obtaining clearance for new products in Europe first, suggesting delayed market entry in the U.S., according to a comprehensive industrywide survey about FDA's 510(k) product review process by researchers at Northwestern University.

26 May 2011

Derma Sciences announces results of DSC127 Phase 2 trial in diabetic foot ulcers at 24-weeks

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that in the follow-up portion of its Phase 2 clinical trial in patients with diabetic foot ulcers, the percentage of patients treated with the therapeutic dose of DSC127 with complete healing at 24 weeks following trial enrollment was 73% in the intent-to-treat population and 85% in the per-protocol population, a difference of 27 and 33 percentage points, respectively, compared with patients treated with placebo/standard of care.

25 May 2011

MIT, ADI partner to research and develop technologies for next-generation patient monitoring devices

Analog Devices, Inc., a global leader in high-performance semiconductors for signal-processing applications and long-time supplier to the medical equipment industry, today announced a collaboration with the Massachusetts Institute of Technology to research and develop technologies for next-generation patient monitoring devices.

25 May 2011

MIT, GE partner to create Medical Electronic Device Realization Center

Supporting its quest through healthymagination to reach more patients with better health care globally, GE has joined with the Massachusetts Institute of Technology (MIT) to create a Medical Electronic Device Realization Center at MIT.

25 May 2011

Nerve stimulation device approved for pain

The Medtronic Inc. has won the CE Mark approval for a peripheral nerve stimulation device for treating chronic back pain. This medical device maker from Minneapolis, Minn. said the implantable device will fit into its neurostimulation business, which operates out of the company's restorative therapies division. That unit was responsible for about $5.42 billion in sales during the nine-month period ended Jan. 28.

From Medtronic 24 May 2011

TZ Medical, Cinterion announce Aera-CT mHealth heart arrhythmia monitoring device

Cinterion, the global leader in cellular machine-to-machine communication modules and a Gemalto company, and TZ Medical, a leading manufacturer of critical-care medical products, today announced Aera-CT, a lightweight and cost effective mHealth heart arrhythmia monitoring device.

24 May 2011

Aptus EndoStapling System receives CE Mark approval

Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced CE Mark approval for the Aptus EndoStapling System. The innovative helical staple technology enables independent endograft fixation, and is designed to mimic the hand suturing performed during open surgical repair of abdominal aortic aneurysms.

From Medtronic 24 May 2011

Elixir DESyne Drug Eluting Coronary Stent System granted CE Mark approval

Elixir Medical Corporation, a developer of product platforms combining state-of-the-art medical devices with advanced pharmaceuticals, announced that it has received CE Mark for its DESyne Drug Eluting Coronary Stent System for the treatment of coronary artery disease.

23 May 2011

Aethlon to introduce new adaptive dialysis-like affinity platform technology at C21 partnering conference

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announces that Chairman and CEO James A. Joyce will present the Aethlon ADAPT™ system in a presentation at the C21 BioVentures™ Life Sciences Partnering Conference.

23 May 2011

Baby boomers becoming the replacement generation

The Associated Press reports that knee and hip replacement surgeries are on the rise for the baby boomer generation, not because of obesity, but because of their efforts to stay fit.

23 May 2011

First Edition: May 23, 2011

Today's headlines include reports about a new poll that shows Americans don't believe Medicare has to be cut in order to balance the budget.

23 May 2011

Boston Healthcare announces acquisition of Alpha Care

Boston Healthcare announced today that it has acquired Alpha Care GmbH, a consulting firm based in Germany that provides health economics and policy solutions for pharmaceutical, medical device, payer and provider organizations.

23 May 2011

McDonald's reacts to protests and calls to fire Ronald

McDonald's Corp has refused to pay heed to the protesters who ask it to assess the impact of its food on childhood obesity, and said its trademark clown Ronald McDonald would be hawking Happy Meals to kids for years to come.

22 May 2011

Accovion establishes new subsidiary in the UK

As a European full-service Clinical Research Organization, Accovion supports local and global projects of all types and phases for the Pharmaceutical, Biotechnology and Medical Device industries.

20 May 2011

Tornier announces launch of Porous Coated Affiniti Stem for shoulder joint replacement surgery

Tornier Inc. the operating subsidiary of Tornier N.V., a leading global medical device company focused on serving extremities specialists who treat orthopedic conditions of the shoulder, elbow, wrist, hand, ankle and foot, today announced the introduction of the Porous Coated Affiniti Stem for shoulder joint replacement surgery.

20 May 2011